Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Steroid 12 shows promise as a targeted treatment for prostate cancer by selectively reducing cell growth and increasing cell death.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Piperonylic acid may help hair growth and treat hair loss.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

MR antagonists may improve skin health and wound healing, especially in aging.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.